OLMESARTAN AMEDA (Accord Healthcare Pty Ltd)
Product name
OLMESARTAN AMEDA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
167 (255 working days)
Active ingredients
Olmesartan medoxomil
Registration type
New generic medicine
Indication
OLMESARTAN AMEDA is indicated for the treatment of hypertension.